Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible | Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 6/05/2023 | Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/13/2023 |
| Deadline: 6/20/2023 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 3/10/2023 |
| Deadline: 6/20/2023 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 3/10/2023 |
| Deadline: 6/21/2023 | Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/10/2023 |
| Deadline: 6/19/2023 | BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/10/2023 |
| Deadline: 6/20/2023 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 3/09/2023 |
| Deadline: 6/05/2023 | Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/09/2023 |
| Deadline: 6/05/2023 | Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/09/2023 |
| Deadline: 5/26/2023 | Congressionally Directed Medical Research Programs -- Ovarian Cancer Research Program -- Clinical Translational Research Award | Department of Defense |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,000,000 | 3/08/2023 |
| Deadline: 6/05/2023 | Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 7/21/2023 | Catalyze: Product Definition – Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $500,000 | 3/07/2023 |
| Deadline: 6/19/2023 | Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 6/19/2023 | Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 7/21/2023 | Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 – Clinical Trials Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 7/21/2023 | Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 7/21/2023 | Catalyze: Product Definition – Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 6/20/2023 | HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 10/18/2023 | NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 6/15/2023 | Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/07/2023 |
| Deadline: 6/12/2023 | Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/06/2023 |
